UROV - Urovant Sciences Ltd. (UROV) CEO Keith Katkin on Q2 2019 Results - Earnings Call Transcript
Urovant Sciences Ltd. (UROV)
Q2 2019 Earnings Conference Call
November 5, 2019 4:30 P.M. ET
Company Participants
Ryan Kubota - Executive Director of Investor Relations
Keith Katkin - Chief Executive Officer
Cornelia Haag-Molkenteller - Chief Medical Officer
Christine Ocampo - Chief Accounting Officer
Ajay Bansal - Senior Vice President, Business Development and Chief Financial Officer
Conference Call Participants
Turner Kufe - JPMorgan
Edward Marks - H.C. Wainwright & Co.
Joon Lee - SunTrust Robinson Humphrey Inc.
Presentation
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Urovant Sciences Fiscal 2019 Second